Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework.

El-Tanani M, Wali AF, Rabbani SA, El-Tanani Y, Rangraze I, Muhana F

Open source

DOI
10.3390/ph19060957
Published
2026 Jun 19
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19060957,
  title = {Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework.},
  author = {El-Tanani M and Wali AF and Rabbani SA and El-Tanani Y and Rangraze I and Muhana F},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19060957},
  url = {https://doi.org/10.3390/ph19060957}
}

RIS

TY  - JOUR
TI  - Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework.
AU  - El-Tanani M
AU  - Wali AF
AU  - Rabbani SA
AU  - El-Tanani Y
AU  - Rangraze I
AU  - Muhana F
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19060957
UR  - https://doi.org/10.3390/ph19060957
ER  - 

APA

M, E., AF, W., SA, R., Y, E., I, R., & F, M. (2026). Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19060957

Source records